Now more than ever, scientists need visibility into life sciences research

▤ Summary

Meteorologists talk about it frequently, and we’ve all experienced it at one time or another — say, when you’re driving down a narrow, winding, country road… at night… in a blizzard. Like if you’re a pharmaceutical researcher tasked with developing a potentially life-saving vaccine in the middle of a pandemic… and you can’t readily find comprehensive information about prior studies of similar viruses. Because less than half of all studies and only about 60% of randomized clinical trials (RCTs) presented at conferences are eventually published in a peer-reviewed journal, often several years after they’ve concluded. Public interest research organization Cochrane studies indicate that the most innovative ideas are often the ones that have the most trouble getting published in peer reviewed journals because the peer-reviewers act as guardians of the status quo. Content in the collection related to COVID-19 is growing rapidly — 239 abstracts are presentations about COVID-19 over the last six months — and nearly 12,000 documents pertain to coronavirus epidemics of the past decade.

▦ Linked Companies

Northern Light Group, LLC

$1M to $5M